Skip to main content
Caplight Logo









Route 92 Medical

Route 92 Medical

Private
West Jordan, UtahHealthcare & Life Scienceshttps://www.route92medical.com/

Last Round

Series F

Extension

Apr 20, 2026

Total Funding Raised

$229.76M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Route 92 Medical is a medical technology company that develops advanced neurovascular solutions for the treatment of acute ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular interventionischemic stroke treatmentaspiration cathetermechanical thrombectomystroke interventionclot removalneurointerventiondelivery cathetermedical deviceneurovascular deviceclinical trialsinterventional neurologystroke centerneurosurgeon

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Route 92 Medical Comparables

Compare Route 92 Medical with similar companies based on industry and business-model similarity.

Route 92 Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Q'Apel Medical
91%
Imperative Care
88%
Wallaby Medical
85%

Route 92 Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series F ExtensionApr 20, 2026
Series FSep 23, 2024
Series FNov 16, 2023
Series EDec 14, 2021
DebtDec 14, 2021
Series D
May 10, 2019

Key People

Founding team and executive leadership

Raj Denhoy

Chief Financial Officer

Executive Team

Kirsten Valley

COO

Executive Team

Route 92 Medical Investors

Notable investors and investment history

Route 92 Medical investors
InvestorRounds
Runway Growth CapitalDebt
The Vertical GroupSeries D, Series E, Series F Extension, Series C, Series A, Series F
InnovaHealth PartnersSeries F Extension, Series F, Series E
U.S. Venture PartnersSeries D, Series E, Series F Extension, Series C, Series A, Series F
Norwest Venture PartnersSeries F Extension, Series F, Series E
Novo HoldingsSeries F Extension, Series F
SectoralSeries F Extension, Series F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 70% MoM.

  • Apr 24, 2026

    Enrolling patients for the SUMMIT MAX randomized controlled trial under FDA IDE.

Route 92 Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Route 92 Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Route 92 Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Jordan, Utah
Employee Range195
Year Founded2015
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?